198 related articles for article (PubMed ID: 18957616)
1. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles.
Mahmoud AM; Szczurek MR; Blackburn BK; Mey JT; Chen Z; Robinson AT; Bian JT; Unterman TG; Minshall RD; Brown MD; Kirwan JP; Phillips SA; Haus JM
Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27796268
[TBL] [Abstract][Full Text] [Related]
3. Endothelin limits insulin action in obese/insulin-resistant humans.
Lteif A; Vaishnava P; Baron AD; Mather KJ
Diabetes; 2007 Mar; 56(3):728-34. PubMed ID: 17327443
[TBL] [Abstract][Full Text] [Related]
4. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.
Mather KJ; Lteif A; Steinberg HO; Baron AD
Diabetes; 2004 Aug; 53(8):2060-6. PubMed ID: 15277386
[TBL] [Abstract][Full Text] [Related]
5. Endothelin A (ET(A)) receptors are involved in augmented adrenergic vasoconstriction and blunted nitric oxide-mediated relaxation of penile arteries from insulin-resistant obese zucker rats.
Sánchez A; Contreras C; Martínez P; Muñoz M; Martínez AC; García-Sacristán A; Hernández M; Prieto D
J Sex Med; 2014 Jun; 11(6):1463-74. PubMed ID: 24697908
[TBL] [Abstract][Full Text] [Related]
6. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Di Daniele N; Mores N; Veneziani A; Cardillo C
J Clin Endocrinol Metab; 2013 Mar; 98(3):1235-41. PubMed ID: 23372172
[TBL] [Abstract][Full Text] [Related]
7. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
8. Vascular Effects of Obestatin in Lean and Obese Subjects.
Schinzari F; Veneziani A; Mores N; Barini A; Di Daniele N; Cardillo C; Tesauro M
Diabetes; 2017 May; 66(5):1214-1221. PubMed ID: 28174289
[TBL] [Abstract][Full Text] [Related]
9. Role of Endothelin-1 Receptors in Limiting Leg Blood Flow and Glucose Uptake During Hyperinsulinemia in Type 2 Diabetes.
Young BE; Padilla J; Finsen SH; Fadel PJ; Mortensen SP
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35084435
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors.
Sánchez A; Martínez P; Muñoz M; Benedito S; García-Sacristán A; Hernández M; Prieto D
Br J Pharmacol; 2014 Dec; 171(24):5682-95. PubMed ID: 25091502
[TBL] [Abstract][Full Text] [Related]
11. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X.
Newby DE; Flint LL; Fox KA; Boon NA; Webb DJ
J Am Coll Cardiol; 1998 Jun; 31(7):1585-90. PubMed ID: 9626838
[TBL] [Abstract][Full Text] [Related]
12. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
Just A; Olson AJ; Arendshorst WJ
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans.
Ahlborg G; Lindström J
J Appl Physiol (1985); 2002 Dec; 93(6):2112-21. PubMed ID: 12391119
[TBL] [Abstract][Full Text] [Related]
14. Insulin stimulates both endothelin and nitric oxide activity in the human forearm.
Cardillo C; Nambi SS; Kilcoyne CM; Choucair WK; Katz A; Quon MJ; Panza JA
Circulation; 1999 Aug; 100(8):820-5. PubMed ID: 10458717
[TBL] [Abstract][Full Text] [Related]
15. Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearm.
Rab A; Dallinger S; Polak K; Pleiner J; Polska E; Wolzt M; Schmetterer L
J Pharmacol Exp Ther; 2004 May; 309(2):692-6. PubMed ID: 14757848
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.
Virdis A; Duranti E; Rossi C; Dell'Agnello U; Santini E; Anselmino M; Chiarugi M; Taddei S; Solini A
Eur Heart J; 2015 Apr; 36(13):784-94. PubMed ID: 24578389
[TBL] [Abstract][Full Text] [Related]
17. Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.
Wenzel RR; Siffert W; Bruck H; Philipp T; Schäfers RF
Pharmacogenetics; 2002 Aug; 12(6):489-95. PubMed ID: 12172218
[TBL] [Abstract][Full Text] [Related]
18. Interaction of endothelin-1 and nitric oxide in endothelial barrier failure in the cat hindlimb.
Porter LP; McNamee JE; Wolf MB
Microcirculation; 2000 Oct; 7(5):347-56. PubMed ID: 11079252
[TBL] [Abstract][Full Text] [Related]
19. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
20. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans.
Baron AD; Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G
J Clin Invest; 1995 Aug; 96(2):786-92. PubMed ID: 7635973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
